Christine Gebski - 29 Feb 2024 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
SVP, Filtration & Chromatography
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
29 Feb 2024
Net transactions value
-$174,569
Form type
4
Filing time
04 Mar 2024, 21:45:48 UTC
Previous filing
13 Nov 2023
Next filing
06 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Award $0 +391 +1.4% $0.000000 29,178 29 Feb 2024 Direct F1
transaction RGEN Common Stock Tax liability $85,730 -447 -1.5% $191.79 28,731 01 Mar 2024 Direct F2
transaction RGEN Common Stock Tax liability $88,839 -461 -1.6% $192.71 28,270 04 Mar 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 391 shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on February 24, 2021. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.
F2 Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Remarks:

SVP, Filtration & Chromatography